Abstract
Raynaud phenomenon (RP) is thought to be an exaggerated vasoactive response to environmental temperatures and emotional stress. Abnormal vascular reactivity is also the presumed mechanism underlying several common and uncommon disorders such as migraine headaches, preeclampsia, and variant angina. While epidemiologic studies (case reports, case series, and some controlled studies) have linked RP and these conditions, there is yet to be any clearly defined systemic vasoreactivity syndrome. Raynaud phenomenon is also a hallmark feature of systemic sclerosis, a disease with components of both vasospasm and structural small vessel disease that may lead to tissue ischemia of the digits. Whether other organ systems in patients with scleroderma also have a component of vasospasm as either an inciting event or contributing factor to damage is yet to be clearly defined. This chapter first examines the possible role of vasospasm in scleroderma outside of the peripheral circulation and RP in playing a role in the pathogenesis of scleroderma renal crisis, pulmonary hypertension, and cardiac disease. This chapter then examines the evidence that may exist linking RP with systemic vascular disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- SSc:
-
Scleroderma
- RP:
-
Raynaud phenomenon
- ECG:
-
Electrocardiogram
- DLCO:
-
Carbon monoxide
- CGRP:
-
Calcitonin gene-related protein
- MINC:
-
Myocardial infarction with normal coronary arteries
References
Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39(4):269–77.
Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of systemic sclerosis patients. Ann Rheum Dis. 2009;10. Epub 2009/03/13. Eng.
Steen VD, Follansbee WP, Conte CG, Medsger Jr TA. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum. 1996;39(4):677–81. PubMed PMID: 8630120.
Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR, et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum. 2008;59(4):591–7. PubMed PMID: 18383403.
Vesely MR, Dilsizian V. Microvascular angina: assessment of coronary blood flow, flow reserve, and metabolism. Curr Cardiol Rep. 2011;13(2):151–8. PubMed PMID: 21234817.
Siegel RJ, O’Connor B, Mena I, Criley JM. Left ventricular function at rest and during Raynaud’s phenomenon in patients with scleroderma. Am Heart J. 1984;108(6):1469–76. PubMed PMID: 6507243.
Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner Jr HN, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med. 1986;105(5):661–8. PubMed PMID: 3767147.
Candell-Riera J, Armadans-Gil L, Simeon CP, Castell-Conesa J, Fonollosa-Pla V, Garcia-del-Castillo H, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum. 1996;39(7):1138–45. PubMed PMID: 8670322.
Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papazoglou S, Papamichael C, et al. Cold-induced coronary Raynaud’s phenomenon in patients with systemic sclerosis. Clin Exp Rheumatol. 1998;16(2):135–40. PubMed PMID: 9536388.
el Tarek G, Yasser AE, Gheita T. Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol. 2006;25(4):487–90. PubMed PMID: 16440131.
Parks JL, Taylor MH, Parks LP, Silver RM. Systemic sclerosis and the heart. Rheum Dis Clin North Am. 2014;40(1):87–102. PubMed PMID: 24268011.
Mizuno R, Fujimoto S, Saito Y, Nakamura S. Cardiac Raynaud’s phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study. Eur J Heart Fail. 2010;12(3):268–75. PubMed PMID: 20071354.
Kahan A, Devaux JY, Amor B, Menkes CJ, Weber S, Nitenberg A, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med. 1986;314(22):1397–402.
Sokoloff L. Some aspects of the pathology of collagen diseases. Bull N Y Acad Med. 1956;32(10):760–7. PubMed PMID: 13364587. Pubmed Central PMCID: 1806016.
Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore). 1974;53(1):1–46. PubMed PMID: 4808710.
Scorza R, Rivolta R, Mascagni B, Berruti V, Bazzi S, Castagnone D, et al. Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis. J Rheumatol. 1997;24(10):1944–8. PubMed PMID: 9330936.
Rosato E, Cianci R, Barbano B, Menghi G, Gigante A, Rossi C, et al. N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis. Acta Pharmacol Sin. 2009;30(9):1283–8. PubMed PMID: 19730428.
Aikimbaev KS, Canataroglu A, Ozbek S, Usal A. Renal vascular resistance in progressive systemic sclerosis: evaluation with duplex Doppler ultrasound. Angiology. 2001;52(10):697–701. PubMed PMID: 11666134.
Yamauchi K, Arimori S. Alterations of glomerular filtration rate during cold exposure in progressive systemic sclerosis: measurement with technetium-99m DTPA. Jpn J Med. 1990;29(2):208–11. PubMed PMID: 2232369.
Kovalchik MT, Guggenheim SJ, Silverman MH, Robertson JS, Steigerwald JC. The kidney in progressive systemic sclerosis: a prospective study. Ann Intern Med. 1978;89(6):881–7. PubMed PMID: 717985.
Bruyn GA, Van Leeuwen MS. Failure of cold pressor testing to induce changes in plasma renin activity or renal duplex sonography in patients with systemic sclerosis. Ann Rheum Dis. 1992;51(8):1022. PubMed PMID: 1417112.
Rozkovec A, Bernstein R, Asherson RA, Oakley CM. Vascular reactivity and pulmonary hypertension in systemic sclerosis. Arthritis Rheum. 1983;26(8):1037–40. PubMed PMID: 6882479.
Ohar JM, Robichaud AM, Fowler AA, Glauser FL. Increased pulmonary artery pressure in association with Raynaud’s phenomenon. Am J Med. 1986;81(2):361–2. PubMed PMID: 3740093.
Naslund MJ, Pearson TA, Ritter JM. A documented episode of pulmonary vasoconstriction in systemic sclerosis. Johns Hopkins Med J. 1981;148(2):78–80. PubMed PMID: 7206403.
Morgan JM, Griffiths M, du Bois RM, Evans TW. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991;99(3):551–6. PubMed PMID: 1899817.
Yamauchi K, Arimori S. Alteration in pulmonary blood flow induced by cold exposure to the hand in progressive systemic sclerosis. Jpn J Med. 1989;28(4):506–9. PubMed PMID: 2810923.
Wise RA, Wigley F, Newball HH, Stevens MB. The effect of cold exposure on diffusing capacity in patients with Raynaud’s phenomenon. Chest. 1982;81(6):695–8. PubMed PMID: 7075304.
Miller MJ. Effect of the cold pressor test on diffusing capacity. Comparison of normal subjects and those with Raynaud's disease and progressive systemic sclerosis. Chest. 1983;84(3):264–6. PubMed PMID: 6884100.
Gastaud M, Dolisi C, Bermon S, Gaudin P, Defauw G, Ardisson JL. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud’s phenomenon. Clin Exp Rheumatol. 1995;13(5):617–21. PubMed PMID: 8575140.
Fahey PJ, Utell MJ, Condemi JJ, Green R, Hyde RW. Raynaud’s phenomenon of the lung. Am J Med. 1984;76(2):263–9. PubMed PMID: 6695950.
Sfikakis PP, Kyriakidis M, Vergos C, Papazoglou S, Georgiakodis F, Toutouzas P, et al. Diffusing capacity of the lung and nifedipine in systemic sclerosis. Arthritis Rheum. 1990;33(11):1634–9. PubMed PMID: 2242061.
Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular response during Raynaud’s phenomenon in progressive systemic sclerosis. Am J Med. 1985;78(2):221–7. PubMed PMID: 3970048.
Mukerjee D, Yap LB, Ong V, Denton CP, Howells K, Black CM, et al. The myth of pulmonary Raynaud’s phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension. Ann Rheum Dis. 2004;63(12):1627–31. PubMed PMID: 15547087.
Nishida A, Kaiya H, Uematsu M, Maeda M, Mori S, Wakabayashi S. Transient global amnesia and Raynaud’s phenomenon in scleroderma. Acta Neurol Scand. 1990;81(6):550–2. PubMed PMID: 2220314.
Grecco MP, Pieroni M, Otero M, Ferreiro JL, Figuerola ML. Sporadic hemiplegic migraine and CREST syndrome. J Headache Pain. 2010;11(2):171–3. PubMed PMID: 20130953. Pubmed Central PMCID: 3452292.
Ferraccioli G, Di Poi E, Di Gregorio F, Giacomuzzi F, Guerra U. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud’s syndrome. Lancet. 1999;354(9196):2135–6. PubMed PMID: 10609825.
Terrier B, Charbonneau F, Touze E, Berezne A, Pagnoux C, Silvera S, et al. Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis. J Rheumatol. 2009;36(7):1486–94. PubMed PMID: 19531752.
Hong P, Pope JE, Ouimet JM, Rullan E, Seibold JR. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol. 2004;31(3):508–13. PubMed PMID: 14994396.
Merla A, Romani GL, Tangherlini A, Di Romualdo S, Proietti M, Rosato E, et al. Penile cutaneous temperature in systemic sclerosis: a thermal imaging study. Int J Immunopathol Pharmacol. 2007;20(1):139–44. PubMed PMID: 17346437.
van Wyk L, van der Marel J, Schuerwegh AJ, Schouffoer AA, Voskuyl AE, Huizinga TW, et al. Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study. Arthritis Res Ther. 2011;13(6):R183. PubMed PMID: 22053948. Pubmed Central PMCID: 3334631.
Hartgill TW, Pirhonen J. Blood pressure rises more in pre-eclampsia than normal pregnancy when acral skin is locally cooled. Hypertens Pregnancy. 2013;32(4):340–54. PubMed PMID: 23844619.
de Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological survey of Raynaud’s phenomenon. Eur J Vasc Surg. 1988;2(3):167–70. PubMed PMID: 3410065.
Zahavi I, Chagnac A, Hering R, Davidovich S, Kuritzky A. Prevalence of Raynaud’s phenomenon in patients with migraine. Arch Intern Med. 1984;144(4):742–4.
Leppert J, Aberg H, Ringqvist I, Sorensson S. Raynaud’s phenomenon in a female population: prevalence and association with other conditions. Angiology. 1987;38(12):871–7. PubMed PMID: 3425973.
O'Keeffe ST, Tsapatsaris NP, Beetham Jr WP. Association between Raynaud’s phenomenon and migraine in a random population of hospital employees. J Rheumatol. 1993;20(7):1187–8. PubMed PMID: 8371215.
Pal B, Gibson C, Passmore J, Griffiths ID, Dick WC. A study of headaches and migraine in Sjogren’s syndrome and other rheumatic disorders. Ann Rheum Dis. 1989;48(4):312–6. PubMed PMID: 2712611. Pubmed Central PMCID: 1003747.
Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJ, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 2013;12(5):454–61. PubMed PMID: 23578775.
Tunis MM, Wolff HG. Analysis of cranial artery pulse waves in patients with vascular headache of the migraine type. Am J Med Sci. 1952;224(5):565–8. PubMed PMID: 12985578.
Mirza AF, Mo J, Holt JL, Kairalla JA, Heft MW, Ding M, et al. Is there a relationship between throbbing pain and arterial pulsations? J Neurosci. 2012;32(22):7572–6. PubMed PMID: 22649235. Pubmed Central PMCID: 3376713.
Hoffmann J, Goadsby PJ. Emerging targets in migraine. CNS Drugs. 2014;28(1):11–7. PubMed PMID: 24318669.
Bunker CB, Terenghi G, Springall DR, Polak JM, Dowd PM. Deficiency of calcitonin gene-related peptide in Raynaud’s phenomenon. Lancet. 1990;336(8730):1530–3. PubMed PMID: 1979366.
Ammann P, Marschall S, Kraus M, Schmid L, Angehrn W, Krapf R, et al. Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. Chest. 2000;117(2):333–8. PubMed PMID: 10669671.
Koh KK, Kim SH, Lee KH, Kwon KS, Kim EJ, Baik SH, et al. Does prevalence of migraine and Raynaud’s phenomenon also increase in Korean patients with proven variant angina? Int J Cardiol. 1995;51(1):37–46. PubMed PMID: 8522395.
O’Keeffe ST, Tsapatsaris NP, Beetham Jr WP. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med. 1992;116(12 Pt 1):985–9. PubMed PMID: 1586109.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hummers, L.K. (2015). Systemic Vasospasm. In: Wigley, F., Herrick, A., Flavahan, N. (eds) Raynaud’s Phenomenon. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1526-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1526-2_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1525-5
Online ISBN: 978-1-4939-1526-2
eBook Packages: MedicineMedicine (R0)